Perceived adverse effects of antiretroviral therapy

Mallory O. Johnson, Edwin Charlebois, Stephen F. Morin, Sheryl L Catz, Rise B. Goldstein, Robert H. Remien, Mary Jane Rotheram-Borus, Joanne D. Mickalian, Lauren Kittel, Farishta Samimy-Muzaffar, Marguerita A. Lightfoot, Cheryl Gore-Felton, Margaret A. Chesney

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Adverse effects from antiretroviral therapy (ARV) for HIV are associated with medication nonadherence. The purposes of this study were to explore group differences in the reporting of adverse effects, identify individual adverse effects that are linked to nonadherence, and to explore the role of coping in the relationship between adverse effects and adherence. Cross-sectional interviews of 2,765 HIV-positive adults on ARV therapies in four U.S. cities were performed using a computerized assessment of self-reported adverse effects, coping self-efficacy, and adherence. There were no gender differences in the rate or severity of adverse effects reported. Latino respondents reported more adverse effects than either White or African Americans. Those taking a protease inhibitor (PI) reported a higher rate and greater severity of adverse effects. Older participants reported fewer adverse effects despite being more likely to be on a regimen containing a PI. Respondents with less than 90% adherence reported greater numbers and severity of adverse effects overall. In multivariate analyses, nausea, skin problems, vomiting, and memory adverse effects were independently related to less than 90% adherence over the prior three days. Coping moderated the relationship between nausea and adherence such that individuals who reported lower coping self-efficacy and experienced nausea were at increased risk for nonadherence, regardless of the length of time on the current ARV regimen. Women and men are similar in their overall reports of adverse effects, and Latinos report more adverse effects to ARVs than White or African American patients. Specific adverse effects (skin problems, memory problems, vomiting, and nausea) are more likely than others to be associated with missing ARV medications. Increasing adaptive coping self-efficacy among patients experiencing nausea may be a particularly effective strategy in increasing medication adherence.

Original languageEnglish (US)
Pages (from-to)193-205
Number of pages13
JournalJournal of Pain and Symptom Management
Volume29
Issue number2
DOIs
StatePublished - Feb 2005
Externally publishedYes

Fingerprint

Nausea
Self Efficacy
Medication Adherence
Protease Inhibitors
Hispanic Americans
African Americans
Vomiting
Therapeutics
Skin
HIV-2
Multivariate Analysis
HIV
Interviews
Surveys and Questionnaires

Keywords

  • Adherence
  • Adverse effects
  • Antiretroviral therapy
  • Coping
  • HAART
  • HIV/AIDS

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Neurology
  • Nursing(all)

Cite this

Johnson, M. O., Charlebois, E., Morin, S. F., Catz, S. L., Goldstein, R. B., Remien, R. H., ... Chesney, M. A. (2005). Perceived adverse effects of antiretroviral therapy. Journal of Pain and Symptom Management, 29(2), 193-205. https://doi.org/10.1016/j.jpainsymman.2004.05.005

Perceived adverse effects of antiretroviral therapy. / Johnson, Mallory O.; Charlebois, Edwin; Morin, Stephen F.; Catz, Sheryl L; Goldstein, Rise B.; Remien, Robert H.; Rotheram-Borus, Mary Jane; Mickalian, Joanne D.; Kittel, Lauren; Samimy-Muzaffar, Farishta; Lightfoot, Marguerita A.; Gore-Felton, Cheryl; Chesney, Margaret A.

In: Journal of Pain and Symptom Management, Vol. 29, No. 2, 02.2005, p. 193-205.

Research output: Contribution to journalArticle

Johnson, MO, Charlebois, E, Morin, SF, Catz, SL, Goldstein, RB, Remien, RH, Rotheram-Borus, MJ, Mickalian, JD, Kittel, L, Samimy-Muzaffar, F, Lightfoot, MA, Gore-Felton, C & Chesney, MA 2005, 'Perceived adverse effects of antiretroviral therapy', Journal of Pain and Symptom Management, vol. 29, no. 2, pp. 193-205. https://doi.org/10.1016/j.jpainsymman.2004.05.005
Johnson, Mallory O. ; Charlebois, Edwin ; Morin, Stephen F. ; Catz, Sheryl L ; Goldstein, Rise B. ; Remien, Robert H. ; Rotheram-Borus, Mary Jane ; Mickalian, Joanne D. ; Kittel, Lauren ; Samimy-Muzaffar, Farishta ; Lightfoot, Marguerita A. ; Gore-Felton, Cheryl ; Chesney, Margaret A. / Perceived adverse effects of antiretroviral therapy. In: Journal of Pain and Symptom Management. 2005 ; Vol. 29, No. 2. pp. 193-205.
@article{cb98a69d37c340b6b462e1e684dc1814,
title = "Perceived adverse effects of antiretroviral therapy",
abstract = "Adverse effects from antiretroviral therapy (ARV) for HIV are associated with medication nonadherence. The purposes of this study were to explore group differences in the reporting of adverse effects, identify individual adverse effects that are linked to nonadherence, and to explore the role of coping in the relationship between adverse effects and adherence. Cross-sectional interviews of 2,765 HIV-positive adults on ARV therapies in four U.S. cities were performed using a computerized assessment of self-reported adverse effects, coping self-efficacy, and adherence. There were no gender differences in the rate or severity of adverse effects reported. Latino respondents reported more adverse effects than either White or African Americans. Those taking a protease inhibitor (PI) reported a higher rate and greater severity of adverse effects. Older participants reported fewer adverse effects despite being more likely to be on a regimen containing a PI. Respondents with less than 90{\%} adherence reported greater numbers and severity of adverse effects overall. In multivariate analyses, nausea, skin problems, vomiting, and memory adverse effects were independently related to less than 90{\%} adherence over the prior three days. Coping moderated the relationship between nausea and adherence such that individuals who reported lower coping self-efficacy and experienced nausea were at increased risk for nonadherence, regardless of the length of time on the current ARV regimen. Women and men are similar in their overall reports of adverse effects, and Latinos report more adverse effects to ARVs than White or African American patients. Specific adverse effects (skin problems, memory problems, vomiting, and nausea) are more likely than others to be associated with missing ARV medications. Increasing adaptive coping self-efficacy among patients experiencing nausea may be a particularly effective strategy in increasing medication adherence.",
keywords = "Adherence, Adverse effects, Antiretroviral therapy, Coping, HAART, HIV/AIDS",
author = "Johnson, {Mallory O.} and Edwin Charlebois and Morin, {Stephen F.} and Catz, {Sheryl L} and Goldstein, {Rise B.} and Remien, {Robert H.} and Rotheram-Borus, {Mary Jane} and Mickalian, {Joanne D.} and Lauren Kittel and Farishta Samimy-Muzaffar and Lightfoot, {Marguerita A.} and Cheryl Gore-Felton and Chesney, {Margaret A.}",
year = "2005",
month = "2",
doi = "10.1016/j.jpainsymman.2004.05.005",
language = "English (US)",
volume = "29",
pages = "193--205",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Perceived adverse effects of antiretroviral therapy

AU - Johnson, Mallory O.

AU - Charlebois, Edwin

AU - Morin, Stephen F.

AU - Catz, Sheryl L

AU - Goldstein, Rise B.

AU - Remien, Robert H.

AU - Rotheram-Borus, Mary Jane

AU - Mickalian, Joanne D.

AU - Kittel, Lauren

AU - Samimy-Muzaffar, Farishta

AU - Lightfoot, Marguerita A.

AU - Gore-Felton, Cheryl

AU - Chesney, Margaret A.

PY - 2005/2

Y1 - 2005/2

N2 - Adverse effects from antiretroviral therapy (ARV) for HIV are associated with medication nonadherence. The purposes of this study were to explore group differences in the reporting of adverse effects, identify individual adverse effects that are linked to nonadherence, and to explore the role of coping in the relationship between adverse effects and adherence. Cross-sectional interviews of 2,765 HIV-positive adults on ARV therapies in four U.S. cities were performed using a computerized assessment of self-reported adverse effects, coping self-efficacy, and adherence. There were no gender differences in the rate or severity of adverse effects reported. Latino respondents reported more adverse effects than either White or African Americans. Those taking a protease inhibitor (PI) reported a higher rate and greater severity of adverse effects. Older participants reported fewer adverse effects despite being more likely to be on a regimen containing a PI. Respondents with less than 90% adherence reported greater numbers and severity of adverse effects overall. In multivariate analyses, nausea, skin problems, vomiting, and memory adverse effects were independently related to less than 90% adherence over the prior three days. Coping moderated the relationship between nausea and adherence such that individuals who reported lower coping self-efficacy and experienced nausea were at increased risk for nonadherence, regardless of the length of time on the current ARV regimen. Women and men are similar in their overall reports of adverse effects, and Latinos report more adverse effects to ARVs than White or African American patients. Specific adverse effects (skin problems, memory problems, vomiting, and nausea) are more likely than others to be associated with missing ARV medications. Increasing adaptive coping self-efficacy among patients experiencing nausea may be a particularly effective strategy in increasing medication adherence.

AB - Adverse effects from antiretroviral therapy (ARV) for HIV are associated with medication nonadherence. The purposes of this study were to explore group differences in the reporting of adverse effects, identify individual adverse effects that are linked to nonadherence, and to explore the role of coping in the relationship between adverse effects and adherence. Cross-sectional interviews of 2,765 HIV-positive adults on ARV therapies in four U.S. cities were performed using a computerized assessment of self-reported adverse effects, coping self-efficacy, and adherence. There were no gender differences in the rate or severity of adverse effects reported. Latino respondents reported more adverse effects than either White or African Americans. Those taking a protease inhibitor (PI) reported a higher rate and greater severity of adverse effects. Older participants reported fewer adverse effects despite being more likely to be on a regimen containing a PI. Respondents with less than 90% adherence reported greater numbers and severity of adverse effects overall. In multivariate analyses, nausea, skin problems, vomiting, and memory adverse effects were independently related to less than 90% adherence over the prior three days. Coping moderated the relationship between nausea and adherence such that individuals who reported lower coping self-efficacy and experienced nausea were at increased risk for nonadherence, regardless of the length of time on the current ARV regimen. Women and men are similar in their overall reports of adverse effects, and Latinos report more adverse effects to ARVs than White or African American patients. Specific adverse effects (skin problems, memory problems, vomiting, and nausea) are more likely than others to be associated with missing ARV medications. Increasing adaptive coping self-efficacy among patients experiencing nausea may be a particularly effective strategy in increasing medication adherence.

KW - Adherence

KW - Adverse effects

KW - Antiretroviral therapy

KW - Coping

KW - HAART

KW - HIV/AIDS

UR - http://www.scopus.com/inward/record.url?scp=20044385406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044385406&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2004.05.005

DO - 10.1016/j.jpainsymman.2004.05.005

M3 - Article

VL - 29

SP - 193

EP - 205

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 2

ER -